These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38482671)

  • 1. Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature.
    Marando A; Zagni M; Negrelli M; Valtorta E; Lauricella C; Motta V; Veronese S; Cerea G; Giannetta LG; Ciarlo G; Signorelli D; Pizzutilo EG; Bonoldi E; Pelosi G
    Pathologica; 2024 Feb; 116(1):13-21. PubMed ID: 38482671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-small cell lung carcinoma with diffuse coexpression of thyroid transcription factor-1 and ΔNp63/p40.
    Hayashi T; Takamochi K; Yanai Y; Mitani K; Tomita H; Mogushi K; Suehara Y; Takahashi F; Suzuki K; Saito T; Yao T
    Hum Pathol; 2018 Aug; 78():177-181. PubMed ID: 29410129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-small cell lung carcinoma with focal coexpression of thyroid transcription factor-1 and Δ Np63/p40: A case report.
    Terada K; Menju T; Date H; Haga H; Yoshizawa A
    Thorac Cancer; 2024 Apr; 15(12):1029-1033. PubMed ID: 38478955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis.
    Vogt AP; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2014 May; 42(5):453-8. PubMed ID: 24166777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of ΔNp63/p40 and TTF1 Within Most of the Same Individual Cells Identifies Life-Threatening NSCLC Featuring Squamous and Glandular Biphenotypic Differentiation: Clinicopathologic Correlations.
    Pelosi G; Bulloni M; Vescio M; Uccella S; Forest F; Leone G; Barberis M; Rahal D; Bossi P; Finzi G; Marchiori D; De Luca M; Sessa F; Harari S; Spinelli M; Viola P; Macrì P; Maria S; Rizzo A; Picone A; Pattini L
    JTO Clin Res Rep; 2021 Nov; 2(11):100222. PubMed ID: 34746884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
    Tran L; Mattsson JS; Nodin B; Jönsson P; Planck M; Jirström K; Botling J; Micke P; Brunnström H
    Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
    Pelosi G; Rossi G; Cavazza A; Righi L; Maisonneuve P; Barbareschi M; Graziano P; Pastorino U; Garassino M; de Braud F; Papotti M
    Int J Surg Pathol; 2013 Jun; 21(3):229-39. PubMed ID: 23486764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p40 & thyroid transcription factor-1 immunohistochemistry: A useful panel to characterize non-small cell lung carcinoma-not otherwise specified (NSCLC-NOS) category.
    Walia R; Jain D; Madan K; Sharma MC; Mathur SR; Mohan A; Iyer VK; Kumar L
    Indian J Med Res; 2017 Jul; 146(1):42-48. PubMed ID: 29168459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological Characteristics and Prognosis Analysis of Lung Carcinoma With p40/TTF1 Coexpression and Lung Adenosquamous Carcinoma: Lung Carcinoma With p40/TTF1 Coexpression Is a Rare Tumor With High Metastatic Potential.
    Gao R; Zhang X; Chen X; Chen X; Jin L; Zheng H; Yu X
    Int J Surg Pathol; 2024 Oct; 32(7):1286-1291. PubMed ID: 38321785
    [No Abstract]   [Full Text] [Related]  

  • 10. Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer.
    Roberts EA; Morrison LE; Behman LJ; Draganova-Tacheva R; O'Neill R; Solomides CC
    Ann Diagn Pathol; 2020 Apr; 45():151454. PubMed ID: 31923744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.
    Rekhtman N; Ang DC; Sima CS; Travis WD; Moreira AL
    Mod Pathol; 2011 Oct; 24(10):1348-59. PubMed ID: 21623384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When tumor doesn't read textbook. Third case of TTF1 and p40 co-expression in the same tumour cells in a non-small cell carcinoma. A potential new entity to consider?
    Spinelli M; Khorshad J; Viola P
    Pathologica; 2019 Jun; 111(2):58-61. PubMed ID: 31388196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.
    Micke P; Mattsson JS; Djureinovic D; Nodin B; Jirström K; Tran L; Jönsson P; Planck M; Botling J; Brunnström H
    J Thorac Oncol; 2016 Jun; 11(6):862-72. PubMed ID: 26872818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancer.
    Ilie M; Beaulande M; Hamila M; Erb G; Hofman V; Hofman P
    Lung Cancer; 2018 Oct; 124():90-94. PubMed ID: 30268486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
    Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
    Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of ΔNp63 expression in lung non-small cell carcinomas.
    Nonaka D
    Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid transcription factor 1 represses the expression of Ki-67 and induces apoptosis in non-small cell lung cancer.
    Zu YF; Wang XC; Chen Y; Wang JY; Liu X; Li X; Li CW; Xie YC; Luo Y; Shang XQ; Guo J
    Oncol Rep; 2012 Nov; 28(5):1544-50. PubMed ID: 22940844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.
    Travis WD; Brambilla E; Noguchi M; Nicholson AG; Geisinger K; Yatabe Y; Ishikawa Y; Wistuba I; Flieder DB; Franklin W; Gazdar A; Hasleton PS; Henderson DW; Kerr KM; Petersen I; Roggli V; Thunnissen E; Tsao M
    Arch Pathol Lab Med; 2013 May; 137(5):668-84. PubMed ID: 22970842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.
    Bishop JA; Teruya-Feldstein J; Westra WH; Pelosi G; Travis WD; Rekhtman N
    Mod Pathol; 2012 Mar; 25(3):405-15. PubMed ID: 22056955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
    Argon A; Nart D; Veral A
    Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.